KRZQ010
  • Details

Potential indications: moderate to severe dry eye

Description:

1. Clinical urgently needed varieties; It is used for the treatment of moderate and severe dry eye.

2. Innovative molecular design: single domain nano antibody developed based on nano antibody technology platform; It has the characteristics of small molecular structure, strong penetration, stable structure, difficult aggregation and high affinity.

E. coli expression, low production cost.


Previous Next
Product information
电商缩略图展示

0

In Stock

已选0

Buy Quantity